Lein Applied Diagnostics, a British company that develops blood glucose measuring for people with diabetes, has announced it has received further investment from its shareholder Seven Spires Investments. The company is seeking more investment to put a non-invasive blood glucose meter into clinical trials.
Venture capital firms used to moan that business angels were unprofessional and hard to work with. But Europe's new breed of angel investor networks appears anything but that, says Mary Lisbeth D'Amico
The concept of angel investing - in which individuals devote both their time and money to nurturing young companies - has evolved over the past decade from an unknown or poorly understand phenomena in many parts of Europe to an established form of finance.
In his first interview since taking up the job, Bruno van Pottelsberghe, the 37-year-old newly appointed chief economist at the European Patent Office, bemoans the failure to create a single EU-wide patent.
For some it was like a very bad Greek tragedy, for others a hoax more naive than the Piltdown man. But Hwang Wo-suk's fall from grace puts the UK on level terms with South Korea in the race to generate embryonic stem cells from cloned embryos.
Venture capitalists are once again funding nanotech start-ups, but their overall investment is small compared with government funding and corporate R&D spending, says to a new report.
Researchers at the Advanced Technology Institute at the University of Surrey recently reported that they have shown and observed a phenomenon called negative differential resistance - holding out the prospect of a new generation of cheap and fast semiconductors.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.